Armistice Capital, LLC Can Fite Bio Pharma Ltd. Transaction History

Armistice Capital, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$0.98 - $2.15 $857,500 - $1.88 Million	-875,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$1.65 - $2.34 $1.44 Million - $2.05 Million	875,000 New	875,000 $1.45 Million

1.1K

Ticker CANF
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,191,500
Market Cap $42.1M
Description
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis; and Phase II clinic...

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Armistice Capital, LLC with notifications on news.